Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
JNJ PFE NVS SNY Real Estate Macroaxis 20 Heavy Metals 
United States GSPC USD ...  |  Company Directory


Processing
Collecting data for JNJ

Johnson quote and profile

 
 Companies |  Insiders  | Dashboard  
     
88.46
  
STOCK
0.00  No Change   0.00%  
Year To Date
61.7189.99
Last 1 Month(s)
84.2388.59
May 23 2013 

Diversification Suggestion

Use Johnson to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Analyze Johnson Johnson Trend or Check current 30 days Johnson correlation with market (S&P 500)
1 Month Beta 0.94  
Highest Price:  
Lowest Price:  
88.59  
84.23  
May 21 2013 
May 01 2013 
Johnson returns are very sensitive to returns on the market. As market goes up or down, Johnson is expected to follow.
Johnson   Johnson llmost one BetaJohnson   Johnson Beta Legend
JNJ United States NYSE
Johnson Johnson
Healthcare
Drug Manufacturers - Major
Benchmark S&P 500
http://www.jnj.com
Contact Number: 732. 524. 0400
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation235.11 B
Shares Outstanding2.81 B
Number of Shares Shorted89.45 M
Revenue68.59 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen JNJ JNJ agains markets  0.00 % No Change  
 United States SP 500   0.83 % Macroaxis: 0.83 Moved Down  
 
 United States NYSE   0.94 % Macroaxis: 0.94 Moved Down  
 
 United States Russel   1.65 % Macroaxis: change 1.65 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Johnson Leadership

Nicholas Valeriani Worldwide Chairman of Diagnostic, Group Chairman and VP of Strategy and Growth
Paul Stoffels Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals and Member of Executive Committee
William Weldon Chairman of the Board
Alex Gorsky Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee

Johnson Price and Market Media

The median price of Johnson for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 85.58 with a coefficient of variation of 1.58. The daily time series for the period is distributed with a sample standard deviation of 1.36, arithmetic mean of 86.08, and mean deviation of 1.15. The Stock received substential amount of media coverage during this period.
Johnson         SP 500
Price Growth (%)
 
1
Johnson and Johnson Unveils New Corporate Branding Campaign04/26/2013Macroaxis: Forbes News
2
New Product Approvals Likely To Spur Growth For Johnson and ...05/01/2013Macroaxis: Seeking Alpha News
3
ExJohnson and Johnson employee files suit citing discriminat...05/07/2013Macroaxis: News
4
Johnson and Johnson Merck and Co. Inc. and What To Watch05/15/2013Macroaxis: News
5
A Brief Look At Johnson and Johnson Surgical Devices Busines...05/22/2013Macroaxis: News

Johnson Summary

Johnson Johnson [JNJ] is traded on New York Stock Exchange in USA. It is located in New Brunswick, NJ and employs 127,600 people. The company currently falls under 'Mega-Cap' category with total capitalization of 247.43 B. Johnson Johnson runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 2.81 B outstanding shares of which 89.45 M shares are currently shorted by investors with about 8.3 days to cover shorted positions.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various solutions in the health care field worldwide. more
Past Market
Over 30
Days
11
Out Of
100
 
Chance of
Less
Than
%
 
Follow Johnson with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Johnson to your reader
 

Johnson Research Report

Johnson vs. Pfizer

Correlation analysis and fundamentals comparison between Johnson Johnson and Pfizer Inc

Johnson Executives

Dominic Caruso CFO, VP of Fin. and Member of Executive Committee

Johnson Directors

Ian Davis Independent Director
Mary Coleman Independent Director
Ronald Williams Director, Member of Compensation Committee and Member of Employee Benefits Committee
Michael Johns Independent Director
William Perez Independent Director

Johnson Management

Michael Ullmann VP, General Counsel and Member of Executive Committee

Johnson Fundamentals

Net Income vs Gross Profit
One Year High vs Working Capital
Net Income vs Revenue
Price to Sales vs Working Capital

Johnson vs Competition

Johnson vs. Pfizer Inc
Johnson vs. Novartis AG
Johnson vs. Sanofi
Johnson vs. Merck Co Inc
Johnson vs. GlaxoSmithKline plc
Johnson vs. BristolMyers Squibb Company
Johnson vs. AstraZeneca PLC
Johnson vs. Eli Lilly and Company
Johnson vs. Impax Laboratories Inc

Johnson May 23 2013 Opportunity Range

Downside Deviation0.7355
Information Ratio(0.07)
Maximum Drawdown2.35
Value At Risk(1.24)
Potential Upside1.1

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium